---
title: "TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer | PFE Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288144701.md"
description: "TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer | PFE Stock News"
datetime: "2026-05-30T04:01:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288144701.md)
  - [en](https://longbridge.com/en/news/288144701.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288144701.md)
generator: "portal-rs"
---

# TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer | PFE Stock News

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer | PFE Stock News

### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [4503.JP](https://longbridge.com/en/quote/4503.JP.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Pfizer aims at air-traffic controllers for Covid-19 vaccine money, WSJ says](https://longbridge.com/en/news/298877913.md)
- [How Concerned Should Income Investors Be About Pfizer's Dividend?](https://longbridge.com/en/news/298813592.md)
- [Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage](https://longbridge.com/en/news/298942655.md)
- [Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC](https://longbridge.com/en/news/298830378.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**